Delivery Order SPE2DB22D2006-SPE2DB25FW2CL
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,605.44 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This federal contract award, valued at $3,210.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product. The contract has a completion date of March 26, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,632.64 firm fixed price delivery order is for RYANODEX 250 MG VIALS, a pharmaceutical product, with a performance period through July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract is for the delivery of RYANODEX 250MG VIAL 1S, a medical supply product, with a ceiling value of $4,816.32 and a performance period ending on July 17, 2025. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.44 firm-fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a medical product, with a period of performance ending on January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $5,958.56, is for the delivery of RYANODEX 250 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. No set-aside designation was used for this award....
- This federal contract award, valued at $5,958.56, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,667,602 units of the pharmaceutical product RYANODEX 250MG VIAL 1S, with a performance period ending on June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $53,627.04 Firm Fixed Price Delivery Order contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of August 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYANODEX 250 MG VIALS. The contract is a firm fixed-price delivery order with a ceiling value of $1,605.44 and a period of performance through June 3, 2025. This contract is not set aside and is awarded as open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $3,210.88 and a performance period through July 9, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2CLDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a ceiling value of $3,210.88. The contract is a Firm Fixed Price Delivery Order with a completion date of July 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This prime contract, designated as SPE2DX, enables Amerisourcebergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp is a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/30/25 |